Software-only AI · Peripheral blood smears

Expert blood morphology, anytime, anywhere.

AIMALABS reads peripheral blood smears with AI on the microscopes and cameras labs already own — no new hardware, no capital cost. A standardised readout in under two minutes, ready for a specialist to confirm.

aíma · Greek for “blood” — the heart of everything we do.

Peripheral blood smear under live AIMALABS analysis
white cell · p 0.98
100× · Wright–Giemsa
AIMALABS · white cell morphologyred cell morphologyplatelet estimate
Recognised by Pfizer Start4HealthConceptionX Deloitte AccelerationEnvolveXLEGG Accelerator
The problem · 01

The gold-standard test most patients never receive.

The peripheral blood smear is the gold standard supporting the diagnosis of leukaemias, anaemias and more. But manual review is slow, depends on scarce specialists, and the machines that automate it cost more than most labs can justify.

86%
of the world’s 5 billion blood counts a year never reach a microscope — 4.3 billion counts where nobody looks at the cells.
15%
of leukaemia patients remain undiagnosed even when the CBC is abnormal — because the smear that would have found them was never reviewed (Leukaemia UK).
10–20 min
per smear for manual review — and results vary observer to observer, when a morphologist is on site at all.
£100k+
capital outlay for existing digital-morphology systems, pricing out most mid-sized labs worldwide.
The problem · 02

The test that finds what the count misses.

A blood count is automated and cheap — it answers how many cells? The smear is one glass slide read under a microscope, and it answers how do they look? That is where the diagnosis actually lives.

BLOOD COUNT (CBC)

“How many cells?”

Automated · 5 billion a year. Fast and cheap — but blind to what the cells look like.

BLOOD SMEAR

“How do they look?”

Manual · 10–20 minutes of expert time. Shape, size and structure of every cell — and 86% of the time it simply is not done.

Six disease families depend on it
~1.92B
Anaemias
patients worldwide
7.7M
Haemoglobinopathies
patients worldwide
1.5–1.8M
Leukaemias
patients worldwide
~1M
Platelet disorders
patients worldwide
~800K
Bone marrow disorders
patients worldwide
Global
Malaria & parasites
endemic worldwide
The problem · 03

How often the diagnosis comes late.

Leukaemia in England, measured across 12,770 cases. Behind every one of these sits the same bottleneck: 10–20 minutes of scarce expert time at a microscope, for every smear, by hand.

1 in 4
leukaemia patients in England experiences an avoidable delay in diagnosis.
37%
are only diagnosed in A&E — versus 21% across all cancers.
1 in 5
are delayed even after visiting their GP multiple times.

Leukaemia UK, “Every Diagnosis Counts” (2025), 12,770 cases in England · emergency-diagnosis rate vs all cancers: Leukaemia UK / NCRAS.

The solution

Any microscope becomes an expert haematologist.

AIMALABS is software only. It runs on the microscope and camera a laboratory already owns, returns a standardised read of the cells in under two minutes, and a morphologist confirms every result in one click. Nothing to buy, nothing to install on the bench.

NO HARDWARE

Zero capital cost

Works on existing microscopes — no analyser, no scanner, no replacement of the bench.

< 2 MIN

An answer while the patient waits

The AI analysis takes under two minutes instead of 10–20 minutes of scarce expert time.

EXPERT SIGNS OFF

Assistive, never autonomous

A qualified morphologist confirms or overrides every result. AIMALABS supports the diagnosis; it never makes one.

How it works

One image in. A clinical readout out.

A software-only platform that works with standard microscopes and cameras — and always keeps a specialist in the loop.

STEP 01

Capture

Photograph or upload the stained smear from any microscope camera.

STEP 02

AI analysis

In under two minutes the model classifies cells and quantifies morphology.

STEP 03

Structured output

White blood cell morphology, ICSH-aligned red cell morphology grading and platelet estimation.

STEP 04

Expert confirms

A specialist reviews and signs off. AIMALABS assists — it never replaces them.

What AIMALABS sees

Real cells. Real-time analysis.

AIMALABS localises and classifies the cells on a stained peripheral smear — white cells, red-cell morphology and platelets — then hands a structured readout to your specialist to confirm.

Peripheral blood smear analysed by AIMALABS
white cell detected
AIMALABS · analysis

Peripheral blood smear (Wright–Giemsa). Coral overlay: an illustrative AIMALABS cell detection.

The improvement

Two ways to read a blood film.

For the patient: an answer before they leave — not a letter weeks later.

 
Manual microscopy
AIMALABS
Time
10–20 min per film
< 2 min for the AI analysis
Accuracy
Operator-dependent, varies by examiner
95–97% operator-independent
Consistency
Varies by operator
Standardised, every time
Availability
At the microscope only
Anywhere, any shift
Capacity
Baseline throughput
faster · 80% time saved
See AIMALABS in action

Watch the demo, the 2-minute video and the pitch.

Three short videos on what AIMALABS does and why it matters.

Demo

Product demo

2-minute video

AIMALABS in two minutes

Pitch

Investor pitch

What it changes

What this means for a laboratory.

WORKFORCE

Scarce experts, better used

Routine screening is handled first-pass, freeing trained scientists for complex cases and quality assurance.

OUT OF HOURS

Cover on every shift

The same standardised read at 3am as at 3pm — no waiting for a morphologist to come on shift.

REACH

Wherever the smear is taken

Software-only delivery brings expert-level morphology to labs and settings that could never justify the hardware.

Ready to see AIMALABS on your own smears?

Whether you’re a laboratory, a hospital, an industry partner or an investor — we’d welcome a short conversation.

Book a demonstration →